DCE-MRI定量参数联合NCAPH检测诊断早期乳腺癌的价值分析

doi:10.11904/j.issn.1002-3070.2025.01.008

实用肿瘤学杂志 ›› 2025, Vol. 39 ›› Issue (1): 56-60.doi: 10.11904/j.issn.1002-3070.2025.01.008

DCE-MRI定量参数联合NCAPH检测诊断早期乳腺癌的价值分析

石长勇¹, 周紫珍¹, 周广林¹, 熊益敏²

1.深圳市龙岗区妇幼保健院(汕头大学医学院龙岗妇幼临床学院)乳腺外科(深圳 518172);
2.深圳市龙岗区妇幼保健院(汕头大学医学院龙岗妇幼临床学院)放射科

收稿日期:2023-11-14 修回日期:2024-12-19 出版日期:2025-02-28 发布日期:2025-03-19
通讯作者: 熊益敏,E-mail:13714606752@qq.com
作者简介:石长勇,男,(1978-),硕士,副主任医师,从事乳腺癌的临床与基础方向的研究。
基金资助:
深圳市龙岗区经济与科技发展专项资金医疗卫生科技计划项目(编号:LGKCYLWS2020110)

The values of DCE-MRI quantitative parameters combined with NCAPH in the diagnosis of early breast cancer

SHI Changyong¹, ZHOU Zizhen¹, ZHOU Guanglin¹, XIONG Yimin²

1. Department of Breast Surgery,Longgang District Maternity & Child Healthcare Hospital of Shenzhen City(Longgang Maternity and Child Institute of Shantou University Medical College),Shenzhen 518172,China;
2. Department of Radiology,Longgang District Maternity & Child Healthcare Hospital of Shenzhen City(Longgang Maternity and Child Institute of Shantou University Medical College)

Received:2023-11-14 Revised:2024-12-19 Online:2025-02-28 Published:2025-03-19

摘要/Abstract

摘要： 目的分析动态增强磁共振成像(dynamic contrast enhanced-magnetic resonance imaging,DCE-MRI)定量参数联合染色体凝聚素I复合物H亚单位(non-SMC condensinⅠcomplex subunit H,NCAPH)检测,对早期乳腺癌诊断的价值。方法选取2020年3月—2022年3月于深圳市龙岗区妇幼保健院乳腺外科就诊的96例乳腺结节患者为研究对象,均行DCE-MRI检查,记录转运常数(Ktrans)及速率常数(Kep);实时荧光定量聚合酶链反应(qRT-PCR)检测血清NCAPH mRNA表达水平;以病理检查结果为金标准,病理诊断为乳腺结节患者为良性组,乳腺癌患者为乳腺癌组,比较良性组与乳腺癌组之间DCE-MRI定量参数Ktrans、Kep及血清NCAPH mRNA的差异,分析Ktrans、Kep、血清NCAPH mRNA及三者联合诊断早期乳腺癌的准确率、敏感度、特异度差异,采用Kappa检验法比较其与病理结果的一致性。结果经病理检查结果证实,96例乳腺结节患者中良性结节31例、乳腺癌患者65例;乳腺癌组Ktrans、Kep及NCAPH mRNA均显著高于良性组(P＜0.05);Ktrans、Kep及NCAPH联合应用诊断早期乳腺癌的AUC为0.944,明显高于Ktrans、Kep单独诊断,其敏感度、特异度分别为96.92%、77.42%;Ktrans、Kep联合NCAPH检出假阳性7例,假阴性2例,Kappa值为0.776(P＜0.05),与病理结果一致性较好;DCE-MRI定量参数联合NCAPH诊断早期乳腺癌的敏感度明显高于DCE-MRI定量参数、血清NCAPH单独诊断(P＜0.05)。结论乳腺癌患者DCE-MRI定量参数Ktrans、Kep及血清NCAPH mRNA表达水平均较高,Ktrans、Kep联合血清NCAPH检测诊断早期乳腺癌具有一定临床应用价值。

关键词: 动态增强磁共振成像, 转运常数, 速率常数, 染色体凝聚素I复合物H亚单位, 乳腺癌

Abstract: Objective The aim of this study was to analyze the value of quantitative parameters of dynamic contrast enhanced magnetic resonance imaging(DCE-MRI)combined with the detection of non-SMC condensing Ⅰ complex subunit H(NCAPH)in the diagnosis of early breast cancer. Methods Ninety-six patients with breast nodules who were treated in the department of Breast Surgery at Longgang District Maternity & Child Healthcare Hospital in Shenzhen from March 2020 to March 2022 were selected as the study objects.DCE-MRI examination was performed on all patients,and transport constant(Ktrans)and rate constant(Kep)were recorded.Real-time fluorescence quantitative polymerase chain reaction(qRT-PCR)was used to detect the expression of serum NCAPH mRNA.Based on the results of pathological examination as the gold standard,the patients with breast nodules diagnosed pathologically as the benign group and the patients with breast cancer as the breast cancer group,the differences of DCE-MRI quantitative parameters Ktrans,Kep and serum NCAPH mRNA between the benign group and the breast cancer group were compared.The accuracy,sensitivity and specificity of serum NCAPH mRNA and their combination in the diagnosis of early breast cancer were different.Kappa test was used to compare the consistency with the pathological results. Results The results of pathological examination confirmed that there were 31 benign nodules and 65 breast cancer in 96 patients with breast nodules.Ktrans,Kep and NCAPH mRNA in the breast cancer group were significantly higher than those in the benign group(P＜0.05);The AUC of Ktrans,Kep and NCAPH in the diagnosis of early breast cancer was 0.944,which was significantly higher than that of Ktrans and Kep alone,with the sensitivity and specificity of 96.92% and 77.42%,respectively;Ktrans and Kep combined with NCAPH detected 7 false positives and 2 false negatives,with a Kappa value of 0.776(P＜0.05),which was consistent with the pathological results;The sensitivity of DCE-MRI quantitative parameters combined with NCAPH in the diagnosis of early breast cancer was significantly higher than that of DCE-MRI quantitative parameters and serum NCAPH alone(P＜0.05). Conclusion The expression of Ktrans,Kep and serum NCAPH mRNA in breast cancer patients with DCE-MRI quantitative parameters is high.Ktrans,Kep combined with serum NCAPH detection has certain clinical values in the diagnosis of early breast cancer.

Key words: Dynamic contrast enhanced-magnetic resonance imaging, Transport constant, Rate constant, Non-SMC condensing Ⅰ complex subunit H, Breast cancer

中图分类号:

R737.9

石长勇, 周紫珍, 周广林, 熊益敏. DCE-MRI定量参数联合NCAPH检测诊断早期乳腺癌的价值分析[J]. 实用肿瘤学杂志, 2025, 39(1): 56-60.

SHI Changyong, ZHOU Zizhen, ZHOU Guanglin, XIONG Yimin. The values of DCE-MRI quantitative parameters combined with NCAPH in the diagnosis of early breast cancer[J]. Journal of Practical Oncology, 2025, 39(1): 56-60.

参考文献

1 Katsura C,Ogunmwonyi I,Kankam HK,et al.Breast cancer:presentation,investigation and management[J].Br J Hosp Med(Lond),2022,83(2):1-7.
2 Barzaman K,Karami J,Zarei Z,et al.Breast cancer:biology,biomarkers,and treatments[J].Int Immunopharmacol,2020,84:106535.
3 Wilkinson L,Gathani T.Understanding breast cancer as a global health concern[J].Br J Radiol,2022,95(1130):20211033.
4 Thawani R,Gao L,Mohinani A,et al.Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy:a preliminary study[J].BMC Med Imaging,2022,22(1):1-11.
5 Liang X,Chen X,Yang Z,et al.Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer[J].BMC Cancer,2022,22(1):1250.
6 Sun Y,Wang X,Wen H,et al.Expression and clinical significance of the NCAPH,AGGF1,and FOXC2 proteins in serous ovarian cancer[J].Cancer Manag Res,2021,13(3):7253-7262.
7 Qiu X,Gao Z,Shao J,et al.NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics[J].Ann Hum Genet,2020,84(6):437-446.
8 Kim B,Kim SW,Lim JY,et al.NCAPH is required for proliferation,migration and invasion of non-small-cell lung cancer cells[J].Anticancer Res,2020,40(6):3239-3246.
9 秦敏.VTIQ结合CDFI极大提高对乳腺BI-RADS4类良恶性病变的诊断效能[J].基因组学与应用生物学,2019,38(4):1876-1882.
10 Brahimetaj R,Willekens I,Massart A,et al.Improved automated early detection of breast cancer based on high resolution 3D micro-CT microcalcification images[J].BMC Cancer,2022,22(1):162.
11 宋伟,张禹,张茜,等.DWI和DCE-MRI定量参数鉴别良恶性软组织肿瘤的价值[J].放射学实践,2022,37(4):498-503.
12 赵娓娓,宦怡,郑敏文,等.DCE-MRI定量参数预测胰腺癌组织生物学特征的初步研究[J].放射学实践,2021,36(4):502-506.
13 王志远,吴海龙,李淑豪,等.IVIM-DWI与DCE-MRI定量参数鉴别乳腺良恶性肿瘤的对照研究[J].放射学实践,2021,36(12):1514-1519.
14 赵振江,晋果果,王传珍,等.不同分子亚型乳腺癌患者动态增强MRI定量参数:容量转移(Ktrans)、速率常数(Kep)的变化研究[J].实用癌症杂志,2019,34(10):1669-1672.
15 Li C,Meng J,Zhang T.NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma[J].Sci Rep,2022,12(1):9578.
16 Liao L,Cheng H,Liu S.Non-SMC condensin I complex subunit H promotes the malignant progression and cisplatin resistance of breast cancer MCF-7 cells[J].Oncol Lett,2022,24(3):317.
17 Zhou WM,Wu GL,Huang J,et al.Low expression of PDK1 inhibits renal cell carcinoma cell proliferation,migration,invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway[J].Cell Signal,2019,56(1):1-14.
18 Ichikawa R,Kawasaki R,Iwata A,et al.MicroRNA-126-3p suppresses HeLa cell proliferation,migration and invasion,and increases apoptosis via the PI3K/PDK1/AKT pathway[J].Oncol Rep,2020,43(4):1300-1308.
19 Wang M,Qiao X,Cooper T,et al.HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway[J].Cell Death Dis,2020,11(12):1049.
20 秦恺,叶飞,顾桂源,等.磁共振动态增强参数及miR-27、miR-155表达与乳腺癌的关联性[J].影像科学与光化学,2022,40(2):263-268.

[1]	谷文, 周澜, 贾燕妮, 黄卫东. QLU-C10D量表在乳腺癌患者中测量属性的验证研究[J]. 实用肿瘤学杂志, 2025, 39(1): 49-55.
[2]	张宇晴, 荆晶, 刘兆良, 安静, 安巍巍. MZB1的可变剪接事件是乳腺癌内分泌治疗耐药的潜在生物标志物[J]. 实用肿瘤学杂志, 2024, 38(5): 313-322.
[3]	杨闽叶, 鲜童丞, 刘景建, 别俊, 王杰, 罗义. IL-23在乳腺癌组织中的表达及其与患者临床病理特征的相关性[J]. 实用肿瘤学杂志, 2024, 38(5): 323-329.
[4]	刘冬, 张太娟, 党计锋. 炎症反应驱动乳腺癌转移的研究进展[J]. 实用肿瘤学杂志, 2024, 38(5): 336-341.
[5]	李倩妮, 徐灵燕, 李健, 姚雪佩, 刘美娜. 乳腺癌多维治疗质量纵向评价的趋势分析[J]. 实用肿瘤学杂志, 2024, 38(4): 213-220.
[6]	高光强, 王发琳, 李娟, 田虹, 果思伽, 于晓兰, 杨婷婷, 刘家仁. β-紫罗兰酮通过NF-κB途径抑制乳腺癌细胞增殖[J]. 实用肿瘤学杂志, 2024, 38(4): 254-261.
[7]	邵禹铭, 朱坤兵, 张洁. SP/NK-1R系统在乳腺癌中的研究进展[J]. 实用肿瘤学杂志, 2024, 38(4): 268-272.
[8]	殷海燕, 淳志明, 马巧君, 成涵, 丁高恒, 张海燕, 刘玉琴. 2019年甘肃省肿瘤登记地区女性乳腺癌流行特征及2010-2019年趋势分析[J]. 实用肿瘤学杂志, 2024, 38(3): 141-148.
[9]	黑龙江省医学会乳腺肿瘤学组. 黑龙江省乳腺癌HER2低表达临床病理诊断专家共识(2024版)[J]. 实用肿瘤学杂志, 2024, 38(2): 71-78.
[10]	孟凡岗, 陈飞, 甄立军. DLX2对乳腺癌细胞增殖、迁移、侵袭、凋亡及乳腺癌干细胞特性的影响[J]. 实用肿瘤学杂志, 2024, 38(2): 88-95.
[11]	郑鹏飞, 董良鹏, 高延鑫, 张一夫, 秦双. 白细胞介素-38对乳腺癌患者CD8⁺T淋巴细胞功能的影响[J]. 实用肿瘤学杂志, 2024, 38(1): 30-36.
[12]	谢俊岭. 活化白细胞黏附分子在乳腺癌中的研究进展[J]. 实用肿瘤学杂志, 2024, 38(1): 45-49.
[13]	冯楚然, 曹剑钊, 陈子印, 张大昕, 鲁海玲. 乳腺癌放射性心脏损伤及其预防措施的研究进展[J]. 实用肿瘤学杂志, 2023, 37(6): 513-518.
[14]	赵诗璐, 庞达. 乳腺癌预后相关基因的生物信息学筛选与分析[J]. 实用肿瘤学杂志, 2023, 37(5): 422-428.
[15]	初思彤, 许庆勇. 三阴性乳腺癌免疫治疗耐药机制的研究进展[J]. 实用肿瘤学杂志, 2023, 37(5): 449-453.

DCE-MRI定量参数联合NCAPH检测诊断早期乳腺癌的价值分析

The values of DCE-MRI quantitative parameters combined with NCAPH in the diagnosis of early breast cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价